FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

4074501000001101: Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072401000001114 Report only serious adverse reactions to the Committee on Safety of Medicines en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829401000001111 Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report only serious adverse reactions to the Committee on Safety of Medicines Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lentizol 50mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tryptizol 25mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tryptizol 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dothapax 25mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prepadine 75mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prepadine 25mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prothiaden 75mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prothiaden 25mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Desipramine hydrochloride 25mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Pertofran 25mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Clomipramine hydrochloride 75mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maprotiline hydrochloride 50mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maprotiline hydrochloride 25mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maprotiline hydrochloride 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lofepramine 70mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lofepramine 70mg/5mL s/f suspension - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Feprapax 70mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lomont 70mg/5mL s/f suspension CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Imipramine hydrochloride 25mg/5mL syrup CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nortriptyline 25mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nortriptyline 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Allegron 25mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Allegron 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mianserin hydrochloride 30mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mianserin hydrochloride 20mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mianserin hydrochloride 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maprotiline hydrochloride 75mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Metoclopramide hydrochloride 30mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Metoclopramide hydrochloride 15mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Primperan 5mg/5mL syrup CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Primperan 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mygdalon 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maxolon High Dose 100mg/20mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maxolon 10mg/2mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Metoclopramide hydrochloride 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Hyoscine hydrobromide 1mg/72hours transdermal patch - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Scopoderm TTS transdermal patch CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Hyoscine hydrobromide 300micrograms tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Domperidone 30mg suppository - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Domperidone 5mg/5mL suspension - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Domperidone 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Vivadone 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Domilium 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Motilium 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Motilium 30mg suppository CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Motilium 5mg/5mL suspension CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dimenhydrinate 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dramamine 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cyclizine lactate 50mg/1mL injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cyclizine hydrochloride 50mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dutonin 50mg+100mg+200mg treatment initiation tablet pack CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nefazodone hydrochloride 50mg+100mg+200mg initiation tablet pack - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dutonin 200mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dutonin 100mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nefazodone hydrochloride 200mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nefazodone hydrochloride 100mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Efexor XL 150mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Venlafaxine 150mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Efexor XL 75mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Venlafaxine 75mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Efexor 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Venlafaxine 50mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Efexor 75mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Efexor 37.5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Venlafaxine 75mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluoxetine 60mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prozac 20mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prozac 20mg/5mL liquid CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluoxetine 20mg/5mL oral liquid - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluoxetine 20mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluvoxamine maleate 100mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Faverin 100mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluvoxamine maleate 50mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Faverin 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tryptophan 500mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Optimax 500mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Flupentixol 1mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Flupentixol 500micrograms tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluanxol 1mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluanxol 500micrograms tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Amitriptyline hydrochloride+perphenazine 10mg/2mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Amitriptyline hydrochloride+perphenazine 25mg/2mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tranylcypromine+trifluoperazine 10mg/1mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluphenazine hydrochloride+nortriptyline 500micrograms/10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Fluphenazine hydrochloride+nortriptyline 1.5mg/30mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Triptafen-M tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Triptafen tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Parstelin tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Motival tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zofran Flexi-amp 8mg/4mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zofran Flexi-amp 4mg/2mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ondansetron 8mg/4mL injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zofran 8mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zofran 4mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ondansetron 8mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ondansetron 4mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ondansetron 4mg/2mL injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prepulsid Quicklet 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cisapride 20mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cisapride 5mg/5mL oral suspension - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Prepulsid 5mg/5mL oral suspension CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier

Start Previous Page 90 of 118 Next End

This concept is not in any reference sets

Back to Start